Teleflex Inc (N:TFX)

Business Focus: Medical Equipment, Supplies & Distribution

May 07, 2024 06:30 am ET
Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early
Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies, today announced the presentation of new research findings from the 2024 American Urological Association Annual Meeting in San Antonio, TX, May 3 – 6, 2024, showcasing...
May 06, 2024 06:30 am ET
Teleflex Announces Quarterly Dividend
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable June 14, 2024, to shareholders of record at the close...
May 02, 2024 06:30 am ET
Teleflex Reports First Quarter Financial Results and Full Year 2024 Outlook
Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the first quarter ended March 31, 2024. First quarter financial summary Revenues of $737.8 million, up 3.8% compared to the prior year period; up 3.8% on...
May 01, 2024 06:30 am ET
Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024 American Urological Association Annual Meeting
Additional studies examine post-surgery medication use, rates of hospitalization and adverse events of standard BPH treatments -Teleflex unveils latest advancements in BPH treatment with UroLift™ 2 System with Advanced Tissue Control (ATC) designed...
Apr 30, 2024 06:45 am ET
Teleflex Announces the Limited Market Release of the Wattson™ Temporary Pacing Guidewire
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that the Wattson™ Temporary Pacing Guidewire limited market release has commenced at Columbia University Irving Medical Center. The first cases...
Apr 30, 2024 06:30 am ET
Teleflex to Present at the BofA Securities 2024 Health Care Conference
Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the BofA Securities 2024 Health Care Conference at the Encore Hotel in Las Vegas, Nevada, on Tuesday, May 14, 2024, at 2:20 p.m. (PT). A live...
Apr 18, 2024 06:30 am ET
Teleflex Announces First Quarter 2024 Earnings Conference Call Information
Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its first quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, May 2, 2024. To participate in the conference call, please...
Apr 02, 2024 06:30 am ET
Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types
Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the upcoming full market release of the Advanced Tissue Control (ATC) feature on its unified UroLift™ 2 System platform designed for the treatment...
Mar 28, 2024 06:30 am ET
Teleflex’s Climate Targets Validated by the Science Based Targets Initiative
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced its near- and long-term climate change targets have been validated by the Science Based Targets initiative (SBTi). The announcement comes ahead of...
Mar 14, 2024 04:09 pm ET
Glancy Prongay & Murray LLP Announces Investigation of Teleflex Incorporated (TFX)
Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Teleflex Incorporated (NYSE: TFX) concerning the Company and its directors’ and officers’ possible violations of state laws.
Feb 22, 2024 06:45 am ET
Teleflex Announces Quarterly Dividend
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable March 15, 2024, to shareholders of record at the close...
Feb 22, 2024 06:30 am ET
Teleflex Reports Fourth Quarter and Full Year 2023 Financial Results
Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the fourth quarter ended December 31, 2023. Fourth quarter financial summary Revenues of $773.9 million, reflective of five fewer shipping days...
Feb 20, 2024 06:30 am ET
Teleflex to Present at the 45th Annual Raymond James Institutional Investors Conference
Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 45th Annual Raymond James Institutional Investors Conference at the JW Marriott Orlando Grande Lakes, Orlando, FL, on Tuesday, March 5, 2024,...
Feb 08, 2024 06:30 am ET
Teleflex Announces Fourth Quarter 2023 Earnings Conference Call Information
Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, February 22, 2024. To participate in the conference call, please...
Jan 09, 2024 06:30 am ET
Teleflex now offers its Titan SGS™ Stapler with Staple Line Reinforcement
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that the Titan SGS™ Stapler—the only purpose-built stapler for gastric tissue with a specific indication for sleeve pouch creation in bariatric...
Dec 26, 2023 06:30 am ET
Teleflex to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 42nd Annual J.P. Morgan Healthcare Conference at The Westin St. Francis in San Francisco, California, on Tuesday, January 9, 2024, at 3:00 p.m....
Dec 06, 2023 09:36 am ET
Glancy Prongay & Murray LLP Announces Investigation of Teleflex Incorporated (TFX)
Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Teleflex Incorporated (NYSE: TFX) concerning the Company and its directors’ and officers’ possible violations of state laws.
Dec 05, 2023 06:30 am ET
Teleflex Awarded Peripheral Access Agreement with Premier, Inc.
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded the Peripheral Access purchasing agreement with Premier, Inc. Effective December 1st, 2023, the new agreement allows Premier...
Nov 16, 2023 06:30 am ET
Teleflex Announces First Patient Enrollment in ACCESS-MANTA™ Registry
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the first patient enrollment in a clinical registry that is intended to examine and collect data on outcomes of contemporary on-label use of the...
Nov 14, 2023 06:45 am ET
Large-Scale Real-World Study Demystifies UroLift™ System Durability and Reinforces Superior Patient Experience for Men With Enlarged Prostate Compared to Leading Surgical Treatments
Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, announced today that a new peer-reviewed study in the Nature journal Prostate Cancer and Prostatic Diseases reinforces the position of the UroLift™ System as the...
Nov 14, 2023 06:30 am ET
Teleflex to Present at the 35th Annual Piper Sandler Healthcare Conference
Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 35th Annual Piper Sandler Healthcare Conference at The Lotte New York Palace, New York, NY, on Tuesday, November 28, 2023 at 11:30 a.m. (ET)....
Nov 02, 2023 06:45 am ET
Teleflex Announces Quarterly Dividend
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable December 15, 2023, to shareholders of record at the...
Nov 02, 2023 06:30 am ET
Teleflex Reports Third Quarter Financial Results and Full Year 2023 Outlook
Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the third quarter ended October 1, 2023. Third quarter financial summary Revenues of $746.4 million, up 8.7% compared to the prior year period; up 7.4% on a...
Oct 31, 2023 06:30 am ET
Teleflex to Present at the Jefferies London Healthcare Conference
Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Jefferies London Healthcare Conference, on Tuesday, November 14, 2023, at 9:00 a.m. (GMT). A live audio webcast of the conference...
Oct 19, 2023 06:30 am ET
Teleflex Announces Third Quarter 2023 Earnings Conference Call Information
Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its third quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, November 2, 2023. To participate in the conference call, please...
Oct 10, 2023 05:00 pm ET
Teleflex Completes Acquisition of Palette Life Sciences
Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced that it has completed the previously announced acquisition of Palette Life Sciences AB. The acquisition adds Barrigel®, a biodegradable sculptable...
Sep 15, 2023 06:30 am ET
Teleflex Selected to Exhibit Arrow™ VPS Rhythm™ DLX Device and Arrow™ PICCs preloaded with the NaviCurve™ Stylet at Vizient Innovative Technology Exchange
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has been selected to exhibit Arrow™ VPS Rhythm™ DLX Device and Arrow™ PICCs preloaded with the NaviCurve™ Stylet at the Vizient Innovative...
Sep 12, 2023 06:30 am ET
New Survey Highlights the Quality of Life Impact of an Enlarged Prostate
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced results of its new survey showing that symptoms of an enlarged prostate, also known as benign prostatic hyperplasia (BPH), can interrupt travel...
Aug 30, 2023 06:30 am ET
Teleflex to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Morgan Stanley 21st Annual Global Healthcare Conference at the Sheraton New York, on Wednesday, September 13, 2023, at 11:30 a.m. (ET). A live...
Aug 21, 2023 06:30 am ET
Teleflex Announces Extension of Arrow™ ErgoPack™ Complete System to Hemodialysis and Large Bore Central Venous Catheters
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the release of the Arrow™ ErgoPack™ Complete Kits with Hemodialysis and Large Bore catheters in the United States. This update is intended to...
Aug 03, 2023 06:45 am ET
Teleflex Announces Quarterly Dividend
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable September 15, 2023, to shareholders of record at the...
Aug 03, 2023 06:30 am ET
Teleflex Reports Second Quarter Financial Results and Full Year 2023 Outlook
Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the second quarter ended July 2, 2023. Second quarter financial summary Revenues of $743.3 million, up 5.5% compared to the prior year period; up 5.9% on a...
Aug 01, 2023 06:30 am ET
Teleflex Receives FDA Clearance for Expanded Indication for QuikClot Control+™ Hemostatic Device Usage in Cardiac Surgical Procedures
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the U.S Food and Drug Administration (FDA) has cleared the QuikClot Control+™ Hemostatic Device to include mild and moderate bleeding in cardiac...
Jul 26, 2023 06:44 am ET
Palette Life Sciences Enters Into Definitive Agreement with Teleflex Incorporated
Palette Life Sciences, a fully-integrated global life sciences company dedicated to improving patient outcomes, today announced it has entered into a definitive agreement to be acquired by Teleflex Incorporated (NYSE:TFX), for an upfront cash...
Jul 26, 2023 06:30 am ET
Teleflex to Acquire Palette Life Sciences
Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced it has entered into a definitive agreement to acquire privately-held Palette Life Sciences AB for an upfront cash payment of $600 million at...
Jul 25, 2023 06:30 am ET
Teleflex Awarded National Group Purchasing Agreements with Premier, Inc.
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded three group purchasing agreements with Premier, Inc. Effective August 1st, 2023, the new agreements allow Premier members, at their...
Jul 20, 2023 06:30 am ET
Teleflex Announces Second Quarter 2023 Earnings Conference Call Information
Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its second quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, August 3, 2023. To participate in the conference call, please...
Jul 19, 2023 06:30 am ET
Teleflex Completes Enrollment in Percutaneous Coronary Intervention Study
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the completion of patient enrollment in the prospective multicenter RingerTM PTCA study. RingerTM PTCA is one of two clinical studies evaluating...
Jun 21, 2023 05:00 pm ET
Teleflex Incorporated Announces Global Recall of Rüsch Endotracheal Tubes
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced a global recall of affected batches of the below-mentioned Rüsch Endotracheal Tube products. The Rüsch Endotracheal...
Jun 21, 2023 06:30 am ET
Teleflex Announces Partnership with Insighters Medical for Exclusive Distribution of the Insighters® Video Laryngoscope System
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced a partnership with Shenzhen Insighters Medical Technology Co., Ltd. as the exclusive U.S. distributor of the Insighters® Video Laryngoscope...
Jun 07, 2023 06:30 am ET
Teleflex Receives FDA Clearance for the Wattson® Temporary Pacing Guidewire
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it will feature the Wattson® Temporary Pacing Guidewire – the first commercially available bipolar temporary pacing guidewire designed...
Jun 06, 2023 06:30 am ET
Teleflex Announces the Arrow® EZ-IO® Needle Is Now FDA Cleared For Use in an MRI Environment
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, today announced that the Arrow® EZ-IO® Needle is the first and only Intraosseous (IO) Needle to receive 510(k) clearance from the U.S....
Jun 01, 2023 06:30 am ET
Teleflex Awarded Agreements with Premier, Inc.
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded two group purchasing agreements with Premier, Inc. Effective July 1st, 2023, the new agreements allow Premier members, at their...
May 22, 2023 08:01 am ET
INVESTOR NOTICE - Andrews & Springer LLC Is Investigating Teleflex Incorporated For Potential Securities Fraud Violations and Breaches of Fiduciary Duty - TFX
Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential securities fraud violations and breach of fiduciary duty claims against Teleflex Incorporated...
May 15, 2023 08:01 am ET
SHAREHOLDER NOTICE - Andrews & Springer LLC Is Investigating Teleflex Incorporated For Potential Securities Violations and Breaches of Fiduciary Duty - TFX
Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential securities violations and breach of fiduciary duty claims against Teleflex Incorporated (“Teleflex” or...
May 15, 2023 06:30 am ET
Teleflex Publishes 2022 Global Impact Report
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has published its 2022 Global Impact Report. The report outlines recent accomplishments and sets new targets to support the company’s Corporate...
May 10, 2023 08:01 am ET
TELEFLEX (TFX) SHAREHOLDER ALERT - Andrews & Springer LLC Is Investigating Teleflex Incorporated For Potential Securities Violations and Breaches of Fiduciary Duty
Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential securities violations and breach of fiduciary duty claims against Teleflex Incorporated (“Teleflex” or the “Company”) (NYSE: TFX).
May 08, 2023 06:30 am ET
Teleflex Announces Quarterly Dividend
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable June 15, 2023, to shareholders of record at the close...
May 04, 2023 06:30 am ET
Teleflex Reports First Quarter Financial Results and Full Year 2023 Outlook
Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the first quarter ended April 2, 2023. First quarter financial summary Revenues of $710.9 million, inclusive of five extra shipping days year-over-year, up...
May 03, 2023 06:30 am ET
New Data Highlight that Early Intervention with the UroLift® System Facilitates Long-Term Outcomes for BPH Patients
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced new research findings reinforcing the long-term durability of Prostatic Urethral Lift (PUL) with the UroLift® System and lower complication rates...
May 02, 2023 06:30 am ET
Teleflex Launches New Arrow® VPS Rhythm® DLX Device and NaviCurve™ Stylet in the United States
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the launch of two new devices designed to enhance PICC insertion procedures and reduce the chance of complications. The new Arrow® VPS Rhythm® DLX...
Apr 25, 2023 06:30 am ET
Teleflex to Present at the Bank of America Securities 2023 Health Care Conference
Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Bank of America Securities 2023 Health Care Conference at the Encore Hotel in Las Vegas, Nevada, on Tuesday, May 9, 2023, at 10:00 a.m. (PT)....
Apr 20, 2023 06:30 am ET
Teleflex Announces First Quarter 2023 Earnings Conference Call Information
Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its first quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, May 4, 2023. To participate in the conference call, please utilize...
Mar 29, 2023 06:30 am ET
Teleflex Selects GORE® SEAMGUARD® Bioabsorbable Staple Line Reinforcement Material for Use with Innovative Titan SGS® Stapler
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced a supply agreement with W. L. Gore & Associates, Inc. (Gore) to use Gore’s GORE® SEAMGUARD® Bioabsorbable Staple Line Reinforcement material in a...
Mar 13, 2023 06:30 am ET
UroLift® System Research Data from EAU Highlight Durability and Superior Patient Experience, Along with Benefits of Earlier Treatment for BPH
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced new research from controlled and real-world studies of the Prostatic Urethral Lift (PUL) procedure with the UroLift® System, for treating men with...
Mar 07, 2023 06:30 am ET
Teleflex to Present at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum: Virtual
Thomas Powell, Executive Vice President and Chief Financial Officer, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023, at 12:00 p.m. (ET). A...
Feb 23, 2023 06:45 am ET
Teleflex Announces Quarterly Dividend
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable March 15, 2023, to shareholders of record at the close...
Feb 23, 2023 06:30 am ET
Teleflex Reports Fourth Quarter and Full Year 2022 Financial Results
Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the fourth quarter ended December 31, 2022. Fourth quarter financial summary Revenues of $758.0 million, down 0.5% compared to the...
Feb 22, 2023 06:30 am ET
Teleflex Expands Interventional Cardiology Portfolio with Two New FDA-Cleared Catheter Devices for Use in Complex Percutaneous Coronary Interventions (PCI)
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced key milestones in the release of two new catheters: the U.S. Food and Drug Administration (FDA) 510(k) clearance of the Triumph™ Catheter, and the...
Feb 21, 2023 06:30 am ET
Teleflex to Present at the 44th Annual Raymond James Institutional Investors Conference
Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 44th Annual Raymond James Institutional Investors Conference at the JW Marriott Orlando Grande Lakes, Orlando, FL, on Tuesday, March 7, 2023,...
Feb 09, 2023 06:30 am ET
Teleflex Announces Fourth Quarter 2022 Earnings Conference Call Information
Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, February 23, 2023. To participate in the conference call, please...
Feb 07, 2023 06:30 am ET
Standard Bariatrics, Inc., now part of Teleflex, Awarded Bariatric Stapling Technology Agreement with Premier Inc.
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded a group purchasing organization (GPO) agreement with Premier®, Inc. for the Titan SGS® powered stapling device, expanding access to...
Feb 06, 2023 06:30 am ET
Teleflex Launches National Ad Campaign — “Pit Stop” — to Raise Awareness of the UroLift® System as a Treatment for Enlarged Prostate
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the launch of a new national advertising campaign to raise awareness of the UroLift® System, the leading minimally invasive, outpatient treatment...
Feb 03, 2023 10:59 am ET
Glancy Prongay & Murray LLP Announces Investigation of Teleflex Incorporated
Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Teleflex Incorporated (NYSE: TFX) concerning the Company and its directors’ and officers’ possible violations of state laws.
Dec 27, 2022 06:30 am ET
Teleflex to Present at the 41st Annual J.P. Morgan Healthcare Conference
Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 41st Annual J.P. Morgan Healthcare Conference at The Westin St. Francis Hotel in San Francisco, California, on Tuesday, January 10, 2023, at...
Dec 15, 2022 06:30 am ET
Teleflex Celebrates 400,000 Patients Treated With the Minimally Invasive UroLift® System
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that 400,000 patients have now been treated with the UroLift® System,1 a safe, effective and minimally invasive treatment option for benign...
Nov 21, 2022 06:30 am ET
Teleflex Earns Top Spot in MedReps Best Places to Work 2023 Ranking
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today has announced it was named a MedReps.com 2023 Best Places to Work, earning the Number 1 spot for large companies and making this the sixth consecutive year...
Nov 16, 2022 06:30 am ET
Teleflex to Present at the 34th Annual Piper Sandler Healthcare Conference
Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 34th Annual Piper Sandler Healthcare Conference at The Lotte New York Palace, New York, NY, on Wednesday, November 30, 2022 at 1:30 p.m. (ET)....
Nov 03, 2022 06:30 am ET
Teleflex Announces Worldwide Recall of Gibeck® Iso-Gard® Filter
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced a worldwide recall of affected lots of the below-referenced Gibeck® Iso-Gard® Filter products. The Gibeck® Iso-Gard®...
Nov 01, 2022 06:30 am ET
Teleflex to Present at the Jefferies London Healthcare Conference
Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Jefferies London Healthcare Conference, on Tuesday, November 15, 2022, at 2:40 p.m. (GMT).   A live audio webcast of the conference...
Oct 27, 2022 06:45 am ET
Teleflex Announces Quarterly Dividend
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable December 15, 2022, to shareholders of record at the...
Oct 27, 2022 06:30 am ET
Teleflex Reports Third Quarter Financial Results And Full Year Outlook
Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the third quarter ended September 25, 2022. Third quarter financial summary Revenues of $686.8 million, down 1.9% year-over-year; up 2.4% on a constant...
Oct 25, 2022 06:30 am ET
Published Data Demonstrate Consistent PUL Outcomes for the Treatment of Median Lobe Obstruction Across Controlled and Real-World Settings
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, announced today new data published in the peer-reviewed Journal of Endourology demonstrate the minimally invasive Prostatic Urethral Lift (PUL) procedure using...
Oct 13, 2022 06:30 am ET
Teleflex Announces Third Quarter 2022 Earnings Conference Call Information
Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its third quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, October 27, 2022. To participate in the conference call, please...
Sep 28, 2022 06:30 am ET
Teleflex Completes Acquisition of Standard Bariatrics
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that it has completed the previously announced acquisition of Standard Bariatrics, Inc., which has commercialized an innovative powered stapling...
Sep 27, 2022 06:30 am ET
Teleflex launches new Arrow® Pressure Injectable Midline Catheter Portfolio
Teleflex Incorporated (NYSE: TFX) releases their new Arrow® Pressure Injectable Midline portfolio in the US and Canada, designed to help alleviate line identification confusion. Clinicians can choose between the Arrowg+ard Blue Advance® Midline...
Sep 15, 2022 06:30 am ET
Co-Author of the Karolinska 1000 Consecutive MANTA® Vascular Closure Device Study to Present Learnings at the Transcatheter Cardiovascular Therapeutics (TCT) 2022 Conference
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that Dr. Magnus Settergren*, Asssociate Professor at the Karolinska Institutet, Interventional Cardiologist at Karolinska University Hospital, and...
Aug 31, 2022 06:30 am ET
Teleflex to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Morgan Stanley 20th Annual Global Healthcare Conference at the Sheraton New York, on Wednesday, September 14, 2022 at 10:00 a.m. (ET). A live...
Aug 25, 2022 06:30 am ET
Teleflex Announces Collaboration with FundamentalVR, to Improve Training Through Virtual Reality Simulation
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced a new agreement with FundamentalVR, a world leader in virtual reality (VR) integration for medical simulation. The agreement will provide Teleflex...
Aug 22, 2022 06:30 am ET
Teleflex to Expand Its Surgical Portfolio with Differentiated Stapling Technology for Bariatric Surgery
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has entered into a definitive agreement to acquire Standard Bariatrics, Inc. which has commercialized an innovative powered stapling technology...
Aug 01, 2022 06:30 am ET
Teleflex awarded Central Venous Access contract from Vizient
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, has been awarded a contract for the supply of Central Venous Access products from Vizient, Inc., the nation’s largest member-driven healthcare performance...
Jul 29, 2022 06:30 am ET
Teleflex Publishes 2021 Global Impact Report
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that it has published its 2021 Global Impact Report. The report outlines recent accomplishments and organizational changes to support the...
Jul 28, 2022 06:45 am ET
Teleflex Announces Quarterly Dividend
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable September 15, 2022, to shareholders of record at the...
Jul 28, 2022 06:30 am ET
Teleflex Reports Second Quarter Financial Results And Full Year Outlook
Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the second quarter ended June 26, 2022. Second quarter financial summary Revenues of $704.5 million, down 1.3% year-over-year; up 2.3% on a constant...
Jul 21, 2022 06:30 am ET
Teleflex Announces Pocono Raceway NASCAR Event to Raise Visibility of Enlarged Prostate and the Importance of Regular Health Screenings
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that the company is hosting a booth at the Pocono Raceway NASCAR event in Long Pond, Pa., July 22-24, to raise awareness of benign prostatic...
Jul 14, 2022 06:30 am ET
Teleflex Announces Second Quarter 2022 Earnings Conference Call Information
Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its second quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, July 28, 2022. To participate in the conference call, please...
Jul 01, 2022 06:30 am ET
New Data Reinforce Efficacy of the UroLift® System for the Treatment of Enlarged Prostate
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the results of several research studies that further support the safety and efficacy of the UroLift® System for men living with enlarged prostate,...
Jun 22, 2022 06:30 am ET
Teleflex Announces First Patient Enrollment in MANTA Ultra Study
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the first patient enrollment in a clinical study that is intended to demonstrate the safety of MANTA® Vascular Closure Device ultrasound (U/S)...
Jun 01, 2022 06:30 am ET
Teleflex Celebrates June Men’s Health Month with Launch of UroLift® Patient Ambassador Program
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that it is celebrating Men’s Health Month with the launch of the UroLift Patient Ambassador Program, a network of volunteers available to share...
May 20, 2022 06:30 am ET
Teleflex Hosts 2022 Analyst & Investor Day
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices, will provide an update on its business and address its 2023-2025 business growth strategy and financial goals during its 2022 Analyst & Investor Day today in New York...
May 19, 2022 06:30 am ET
Teleflex Announces Regulatory Clearance for its UroLift® System in China for the Treatment of Benign Prostatic Hyperplasia (BPH)
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that it has received National Medical Products Administration (NMPA) approval for its UroLift® System in China for treating benign prostatic...
May 18, 2022 06:30 am ET
Teleflex Announces Health Canada Approval of MANTA® Vascular Closure Device
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today has announced that it received Health Canada approval for the MANTA® Vascular Closure Device – the first commercially available biomechanical vascular...
May 16, 2022 08:30 am ET
3D Systems Announces Establishment of Medical Advisory Board & Appointment of Dr. Stephen K. Klasko as Chair
Today, 3D Systems (NYSE:DDD) announced the formation of the company’s first Medical Advisory Board (MAB) and the appointment of Stephen K. Klasko, MD, MBA as Chair. The primary mission of the MAB will be to provide strategic input, guidance, and...
May 13, 2022 06:30 am ET
Teleflex Announces Full U.S. Commercial Launch of the UroLift® 2 System and UroLift ATC ® Advanced Tissue Control System
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the full U.S. commercial launch of its UroLift® 2 System and UroLift ATC® System, and that it will update the urology community through multiple...
May 02, 2022 06:45 am ET
Teleflex to Host Analyst & Investor Day on May 20, 2022
Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced that the Company will host an Analyst & Investor Day on Friday, May 20, 2022 in New York City. Liam Kelly, Chairman, President and CEO, will be joined by members of the Company’s...
May 02, 2022 06:30 am ET
Teleflex Announces Quarterly Dividend
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable June 15, 2022, to shareholders of record at the close...
Apr 28, 2022 06:30 am ET
Teleflex Reports First Quarter Financial Results And Full Year Outlook
Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the first quarter ended March 27, 2022. First quarter financial summary Revenues of $641.7 million, up 1.2% year-over-year; up 3.2% on a constant currency...
Apr 26, 2022 06:45 am ET
Teleflex Named to Forbes Best Employers for Diversity 2022 List
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has been named to the Forbes Best Employers for Diversity 2022 list. This prestigious award is presented by Forbes and Statista Inc., a...
Apr 26, 2022 06:30 am ET
Teleflex to Present at the Bank of America Securities 2022 Healthcare Conference
Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Bank of America Securities 2022 Healthcare Conference at the Encore Hotel in Las Vegas, Nevada, on Tuesday, May 10, 2022, at 11:20 a.m. (PT)....
Apr 14, 2022 06:30 am ET
Teleflex Announces First Quarter 2022 Earnings Conference Call Information
Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its first quarter 2022 results, and provide an operational update at 8:00 a.m. Eastern Time on Thursday, April 28, 2022. To register for the conference call and receive...
Apr 11, 2022 06:30 am ET
Teleflex Announces the Launch of the UroLift® System in Japan for the Treatment of Benign Prostatic Hyperplasia (BPH)
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, has announced the launch of the UroLift System in Japan for treating benign prostatic hyperplasia (BPH), or enlarged prostate. The UroLift System is now available...
Mar 09, 2022 06:30 am ET
Teleflex to Present at the KeyBanc Life Sciences & MedTech Investor Forum
Thomas Powell, Executive Vice President and Chief Financial Officer, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the KeyBanc Life Sciences & MedTech Investor Forum on Wednesday, March 23, 2022 at 9:45 a.m. (ET). A live audio...
Mar 02, 2022 06:30 am ET
Teleflex to Present at the 43rd Annual Raymond James Institutional Investors Conference
Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 43rd Annual Raymond James Institutional Investors Conference at the JW Marriott Orlando Grande Lakes, Orlando, FL, on Tuesday, March 8, 2022,...
Feb 24, 2022 06:45 am ET
Teleflex Announces Quarterly Dividend
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable March 15, 2022, to shareholders of record at the close...
Feb 24, 2022 06:30 am ET
Teleflex Announces Fourth Quarter and Full-Year 2021 Financial Results
Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the fourth quarter ended December 31, 2021. Fourth quarter financial summary Reported revenues of $761.9 million, up 7.1% year-over-year; up 7.9% on a...
Feb 23, 2022 06:30 am ET
Teleflex Receives FDA Clearance for Expanded Indication for Specialty Catheter and Coronary Guidewire Use in CTO PCI Procedures
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that the U.S. Food and Drug Administration (FDA) has cleared an expanded indication for its specialty catheters and coronary guidewires for use in...
Feb 10, 2022 06:30 am ET
Teleflex Announces Fourth Quarter and Full Year 2021 Earnings Conference Call Information
Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth quarter and full year 2021 financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, February 24, 2022. To register for the...
Jan 04, 2022 06:30 am ET
Teleflex to Present at the 40th Annual J.P. Morgan Healthcare Conference
Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 4:30 p.m. (ET). A live audio webcast of the conference...
Dec 13, 2021 06:30 am ET
Teleflex Receives Reimbursement Approval for the UroLift® System in Japan
Teleflex Incorporated (NYSE: TFX) today announced that the company has received reimbursement approval from the Central Social Insurance Medical Council of Japan (Chuikyo) of its UroLift System for patients who require treatment for benign...
Nov 26, 2021 06:00 pm ET
Teleflex Incorporated Announces Worldwide Recall of Arrow-Trerotola™ Over-The-Wire PTD® Kit Percutaneous Thrombolytic Device: 7FR
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced a worldwide recall of Arrow-Trerotola™ Over-The-Wire PTD® Kit Percutaneous Thrombolytic Device: 7FR. The...
Nov 18, 2021 06:45 am ET
Teleflex Earns Top Spot in MedReps Best Places to Work 2022 Ranking
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, has announced it was named a winner in the MedReps.com Best Places to Work in Medical Sales 2022 survey, earning the Number 1 spot for large companies and making...
Nov 18, 2021 06:30 am ET
Teleflex to Participate in the 33rd Annual Virtual Piper Sandler Healthcare Conference
Thomas Powell, Executive Vice President and CFO, Teleflex Incorporated (NYSE: TFX), is pleased to participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference. From November 22nd to December 2nd, 2021, registered attendees can access...
Nov 04, 2021 06:30 am ET
Teleflex Integrates Medical Education and Training with Explorer Surgical to Expand Urologists’ Access to Procedural Expertise
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, has announced it is combining its leading industry clinical education with the digital platform of Explorer Surgical, a GHX company. This collaboration will...
Nov 03, 2021 06:47 am ET
Teleflex Comments on the Centers for Medicare & Medicaid Services 2022 Medicare Physician Fee Schedule Final Rule
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies today commented on the recently released Centers for Medicare & Medicaid Services (CMS) Calendar Year 2022 Medicare Physician Fee Schedule (MPFS) Final Rule. The...
Oct 29, 2021 06:30 am ET
The UroLift® System Receives Bronze Award for Best New Branded Television Campaign and Honorable Mention in the Best Branded Website Category from DTC Perspectives
Teleflex Incorporated (NYSE: TFX) announced today that the UroLift® System was honored by DTC Perspectives with a Bronze Award in the “Best New Branded Television Campaign” category and an Honorable Mention in the “Best Branded Website” category....
Oct 28, 2021 06:45 am ET
Teleflex Announces Quarterly Dividend
Teleflex Incorporated (NYSE:TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable December 15, 2021 to shareholders of record at the close...
Oct 28, 2021 06:30 am ET
Teleflex Reports Third Quarter 2021 Results and Full Year Outlook
Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the third quarter ended September 26, 2021. Third quarter financial summary Reported revenues of $700.3 million, up 11.5% year-over-year; up 10.3% on a...
Oct 27, 2021 06:30 am ET
Teleflex Completes Enrollment in Cardiac IDE Study
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the completion of patient enrollment in a clinical study evaluating the performance of the QuikClot Control+® Hemostatic Device for mild to...
Oct 14, 2021 06:30 am ET
Teleflex Announces Third Quarter 2021 Earnings Conference Call Information
Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its third quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, October 28, 2021. To register for the conference call and receive...
Sep 14, 2021 06:30 am ET
Teleflex Announces Large-Scale Analysis of Real-World Healthcare Claims Data for Enlarged Prostate Procedures at the American Urological Association 2021 Annual Meeting
Teleflex Incorporated (NYSE:TFX) today announced that new real-world healthcare claims data reveal that the risk of return procedures is lowest after treatment with the UroLift® System among the analyzed benign prostatic hyperplasia (BPH) treatment...
Sep 09, 2021 06:30 am ET
Teleflex Unveils the UroLift Advanced Tissue Control (ATC)® System and the UroLift® 2 System and Real-World Data Presentations at the American Urological Association 2021 Annual Meeting
Teleflex Incorporated (NYSE: TFX) today announced that two new UroLift System products, the UroLift Advanced Tissue Control (ATC) System and the UroLift 2 System, will be launched at the American Urological Association (AUA) 2021 Annual Meeting...
Sep 01, 2021 06:30 am ET
Teleflex to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Morgan Stanley 19th Annual Global Healthcare Conference on Wednesday, September 15, 2021 at 8:00 a.m. (ET). A live audio webcast of the...
Aug 30, 2021 06:30 am ET
New Study Provides Insights into the Biocompatibility and Durability of the UroLift® System in Improving Benign Prostatic Hyperplasia Symptoms
Teleflex Incorporated (NYSE: TFX) today announced the publication of clinical data for the UroLift® System in the peer-reviewed journal Prostate Cancer and Prostatic Disease. This study explains the mechanism of action through which the UroLift...
Aug 26, 2021 06:30 am ET
Teleflex to Present at the Wells Fargo 2021 Virtual Healthcare Conference
Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Wells Fargo 2021 Virtual Healthcare Conference on Thursday, September 9, 2021 at 12:40 p.m. (ET). A live audio webcast of the conference...
Jul 29, 2021 06:45 am ET
Teleflex Announces Quarterly Dividend
Teleflex Incorporated (NYSE:TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable September 15, 2021 to shareholders of record at the...
Jul 29, 2021 06:30 am ET
Teleflex Reports Second Quarter 2021 Results and Full Year Outlook
Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the second quarter ended June 27, 2021. Second quarter financial summary Reported revenues of $713.5 million, up 25.8% year-over-year; up 21.0% on a...
Jul 15, 2021 06:30 am ET
Teleflex Announces Second Quarter 2021 Earnings Conference Call Information
Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its second quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, July 29, 2021. To register for the conference call and receive...
Jul 09, 2021 06:30 am ET
Largest U.S. Healthcare Claims and Utilization Analysis for BPH Procedures Reveals Lowest Overall Complication Rates and Consistent Durability after Treatment with Minimally Invasive UroLift System
Teleflex Incorporated (NYSE:TFX) today announced that the largest U.S. healthcare claims and utilization analysis for benign prostatic hyperplasia (BPH) surgical and minimally invasive procedures reveals that overall complication rates are lowest...
Jul 06, 2021 06:30 am ET
Teleflex Announces Real-World Clinical Data Presentations of the UroLift® System at the 36th Annual European Association of Urology Congress
Teleflex Incorporated (NYSE:TFX) today announced that new data from real-world clinical studies of the UroLift® System for men with benign prostatic hyperplasia (BPH) will be presented at the 36th European Association of Urology (EAU) 2021 Annual...
Jun 28, 2021 05:00 pm ET
Teleflex Completes Divestiture of Respiratory Assets to Medline Industries
Today, Teleflex Incorporated (NYSE:TFX), a leading global provider for healthcare supplies and services, announced it has completed the previously announced divestiture of a significant portion of its Respiratory business to Medline Industries,...
Jun 16, 2021 06:30 am ET
New Data Suggest Men with Urinary Symptoms Often Anticipate Bathroom Needs and Avoid Events and Activities They Enjoy
Teleflex Incorporated (NYSE: TFX) today announced results of a new survey showing that men with urinary symptoms common with an enlarged prostate, also known as benign prostatic hyperplasia or BPH, may anticipate and plan for their urgent and...
Jun 07, 2021 06:30 am ET
Teleflex to Present at the Raymond James 2021 Human Health Innovation Conference
Thomas Powell, Executive Vice President and Chief Financial Officer, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Raymond James 2021 Human Health Innovation Conference on Monday, June 21, 2021 at 8:40 a.m. (ET). A live audio...
May 18, 2021 06:30 am ET
Teleflex Signs Definitive Agreement to Sell Certain Respiratory Assets and Reaffirms Adjusted EPS Guidance
Today, Teleflex Incorporated (NYSE:TFX), a leading global provider for healthcare supplies and services, announced that it has entered into a definitive agreement to sell a significant portion of its Respiratory business to Medline Industries, Inc....
May 11, 2021 06:30 am ET
Teleflex to Present at the UBS Global Healthcare Virtual Conference
May 11, 2021 – Thomas Powell, Executive Vice President and CFO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the UBS Global Healthcare Virtual Conference on Tuesday, May 25, 2021 at 3:00 p.m. (ET). A live audio webcast of the...
May 03, 2021 06:30 am ET
Teleflex Announces Quarterly Dividend
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable June 15, 2021 to shareholders of record at the close of...
Apr 29, 2021 06:30 am ET
Teleflex Reports First Quarter 2021 Results
Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the first quarter ended March 28, 2021. First quarter 2021 net revenues were $633.9 million, an increase of 0.5% compared to the prior year period. Excluding...
Apr 27, 2021 06:30 am ET
Teleflex to Present at the Bank of America Securities 2021 Virtual Health Care Conference
Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Bank of America Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021 at 8:00 a.m. (ET). A live audio webcast of the...
Apr 15, 2021 06:30 am ET
Teleflex Announces First Quarter 2021 Earnings Conference Call Information
Teleflex Incorporated (NYSE: TFX) announced today that financial results for the first quarter 2021 will be released before market open on Thursday, April 29, 2021.  An investor conference call will be held at 8:00 a.m. (ET) on Thursday, April 29,...
Mar 10, 2021 06:30 am ET
Teleflex to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
Jake Elguicze, Treasurer and Vice President of Investor Relations, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Wednesday, March 24, 2021 at 9:15am (ET). A live...
Mar 09, 2021 06:30 am ET
Teleflex Reports 250,000 Patients Treated for Enlarged Prostate With the Minimally Invasive UroLift® System
Teleflex Incorporated (NYSE: TFX) today announced that, globally, 250,000 patients have been treated with the UroLift® System, a proven, minimally invasive approach to treating benign prostatic hyperplasia (BPH). In the United States alone, more...
Feb 25, 2021 06:45 am ET
Teleflex Announces Quarterly Dividend
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable March 15, 2021 to shareholders of record at the close...
Feb 25, 2021 06:30 am ET
Teleflex Reports Fourth Quarter and Full Year 2020 Results; Provides 2021 Guidance
Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the fourth quarter and full year ended December 31, 2020. Fourth quarter 2020 net revenues were $711.2 million, an increase of 4.4% compared to the prior year...
Feb 24, 2021 06:30 am ET
Teleflex Announces Submission of Biologics License Application for Its Investigational Freeze Dried Plasma
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for its...
Feb 23, 2021 06:30 am ET
Teleflex to Present at Barclays Global Healthcare Conference
Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at Barclays Global Healthcare Conference on Tuesday, March 9, 2021 at 10:55 am (ET). A live audio webcast of the conference presentation, along with...
Feb 17, 2021 06:30 am ET
Teleflex Completes Enrollment in CTO-PCI IDE Study
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the completion of patient enrollment in a clinical study evaluating the performance of Teleflex specialty catheters and coronary guidewires in...
Feb 16, 2021 06:30 am ET
Teleflex Named One of America’s Best Employers 2021 by Forbes
Teleflex Incorporated (NYSE: TFX), has been recognized as part of Forbes’ list of America’s Best Employers 2021. The company ranked #26 out of 500 employers in the Mid-Sized Employers category and #2 in the Health Care Equipment & Services...
Feb 16, 2021 06:30 am ET
Teleflex to Present at the Raymond James 42nd Annual Institutional Investors Conference
Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Raymond James 42nd Annual Institutional Investors Conference on Tuesday, March 2, 2021 at 12:30 p.m. (ET). A live audio webcast of the...
Feb 11, 2021 06:30 am ET
Teleflex Announces Fourth Quarter and Full Year 2020 Earnings Conference Call Information
Teleflex Incorporated (NYSE: TFX) announced today that financial results for the fourth quarter and full year 2020 will be released before market open on Thursday, February 25, 2021. An investor conference call will be held at 8:00 a.m. (ET) on...
Jan 20, 2021 06:30 am ET
Published Data Demonstrate Sexual Function Improvement and Preservation with the Minimally Invasive UroLift® System Compared to Medications Prescribed for Benign Prostatic Hyperplasia
Teleflex Incorporated (NYSE: TFX) announced today that new data published in the peer-reviewed journal, European Urology Focus, found that men treated with the Prostatic Urethral Lift (PUL) procedure (using the UroLift® System) showed preservation...
Jan 19, 2021 06:30 am ET
Teleflex continues to deliver COMPLETE confidence with new Arrow® ErgoPack® Complete MAC, PSI Systems
Teleflex Incorporated (NYSE: TFX) continues to deliver COMPLETE confidence with the release of the Arrow® ErgoPack® Complete Multi-Lumen Access Catheter (MAC) System and the Arrow® ErgoPack® Complete Percutaneous Sheath Introducer (PSI) System....
Jan 04, 2021 06:30 am ET
Teleflex to Present at the 39th Annual J.P. Morgan Healthcare Conference
Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 at 8:20 a.m. (ET). A live audio webcast of the conference...
Dec 28, 2020 05:00 pm ET
Teleflex Completes Acquisition of Market Leader in Hemostatic Products
Teleflex Incorporated (NYSE:TFX), a leading global provider for healthcare supplies and services, announced today that it has completed the previously announced acquisition of Z-Medica, LLC, an industry-leading manufacturer of hemostatic products....
Dec 28, 2020 04:22 pm ET
DW Healthcare Partners and Linden Announce Sale of Z-Medica to Teleflex
PARK CITY, Utah, Dec. 28, 2020 /CNW/ -- DW Healthcare Partners ("DWHP") a healthcare-focused private equity firm, announced today the closing of its previously disclosed sale of Z-Medica ("Z-Medica" or "the Company") to Teleflex Incorporated (NYSE: TFX) ("Teleflex"). Z-Medica, a portfolio company of DW Healthcare Partners and Linden Capital Partners ("Linden"), is a leading manufacturer and marketer of patented hemostatic products that enable healthcare providers, military personnel, and first responders to control bleeding and hemorrhaging.
Dec 28, 2020 04:22 pm ET
DW Healthcare Partners and Linden Announce Sale of Z-Medica to Teleflex
PARK CITY, Utah, Dec. 28, 2020 /PRNewswire/ -- DW Healthcare Partners ("DWHP") a healthcare-focused private equity firm, announced today the closing of its previously disclosed sale of Z-Medica ("Z-Medica" or "the Company") to Teleflex Incorporated (NYSE: TFX) ("Teleflex"). Z-Medica, a portfolio company of DW Healthcare Partners and Linden Capital Partners ("Linden"), is a leading manufacturer and marketer of patented hemostatic products that enable healthcare providers, military personnel, and first responders to control bleeding and hemorrhaging.
Dec 03, 2020 06:30 am ET
Teleflex Ranked a Best Place to Work 2021 by MedReps.com
Teleflex Incorporated (NYSE: TFX) today announced that it was named the winner of MedReps.com’s 10th Annual Best Places to Work in Medical Sales 2021 survey for the Large Category Best Medical Device Companies and placed second in the Overall...
Nov 19, 2020 06:30 am ET
Research Reinforcing the Effectiveness and Safety of the UroLift® System in the Real-World Setting Presented at 50th Annual ICS Meeting
Teleflex Incorporated (NYSE: TFX) today announced the results of four studies that were accepted at the ICS 2020 Annual Meeting – Online reinforcing the safety and efficacy of the UroLift® System for the treatment of benign prostatic hyperplasia...
Nov 02, 2020 06:30 am ET
Teleflex to Present at the Stephens Investment Conference 2020
Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Stephens Investment Conference 2020, on Monday, November 16, 2020 at 1:00 p.m. (ET). A live audio webcast of the conference presentation,...
Oct 29, 2020 06:45 am ET
Teleflex Announces Quarterly Dividend
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable December 15, 2020 to shareholders of record at the...
Oct 29, 2020 06:30 am ET
Teleflex Reports Third Quarter 2020 Results
Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the third quarter ended September 27, 2020. Third quarter 2020 net revenues were $628.3 million, a decrease of 3.1% compared to the prior year period....
Oct 28, 2020 05:00 pm ET
Teleflex to Acquire Market Leader in Hemostatic Products
Teleflex Incorporated (NYSE:TFX), a leading global provider for healthcare supplies and services, today announced it has entered into a definitive agreement to acquire privately-held Z-Medica, LLC, an industry-leading manufacturer of hemostatic...
Oct 28, 2020 06:30 am ET
Teleflex Interventional Urology Expands Portfolio with Introduction of the UroLift® Advanced Tissue Control (ATC)™ System
Teleflex Incorporated (NYSE: TFX) today announced the expansion of its UroLift® System portfolio with the introduction of the UroLift® Advanced Tissue Control (ATC)™ System. The new system, which builds on the highly successful UroLift System,...
Oct 27, 2020 06:30 am ET
Teleflex Delivers COMPLETE Confidence with the New Arrow® ErgoPack® Complete CVC System
Teleflex Incorporated (NYSE: TFX) delivers COMPLETE confidence to central line inserters with the release of the Arrow® ErgoPack® Complete CVC System, the most important update to its market-leading1 portfolio of Centrally-Inserted Central...
Oct 19, 2020 06:30 am ET
Teleflex Announces Third Quarter 2020 Earnings Conference Call Information
Teleflex Incorporated (NYSE: TFX) announced today that financial results for the third quarter 2020 will be released before market open on Thursday, October 29, 2020. An investor conference call will be held at 8:00 a.m. (ET) on Thursday, October...
Oct 08, 2020 06:30 am ET
Teleflex Named One of America’s Best-In-State Employers 2020 by Forbes
Teleflex Incorporated (NYSE: TFX), has been recognized as part of Forbes’ annual list of America’s Best-In-State Employers 2020. The company ranked #6 out of 100 employers in the state of Pennsylvania. This prestigious award is presented by Forbes...
Oct 01, 2020 06:30 am ET
Teleflex Announces Expanded Indications for the Arrow® EZ-IO® Intraosseous Vascular Access System
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, has announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the Indications for Use of the...
Sep 02, 2020 06:30 am ET
Teleflex to Present at the Morgan Stanley 18th Annual Global Healthcare Conference
Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Morgan Stanley 18th Annual Global Healthcare Conference on Wednesday, September 16, 2020 at 2:00 p.m. (ET).  A live audio webcast of the...
Aug 26, 2020 06:30 am ET
Teleflex to Present at the Wells Fargo 2020 Virtual Healthcare Conference
Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Wells Fargo 2020 Virtual Healthcare Conference on Wednesday, September 9, 2020 at 12:40 p.m. (ET).  A live audio webcast of the conference...
Aug 18, 2020 06:30 am ET
Teleflex Publishes 2nd Annual Global JOIN Impact Report
Teleflex Incorporated (NYSE: TFX), today announced the publication of its 2nd annual Global JOIN Impact Report. The report outlines the progress the company made in 2019 in the areas of people, environmental sustainability with a focus on...
Jul 30, 2020 06:45 am ET
Teleflex Announces Quarterly Dividend
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock.  The dividend is payable September 15, 2020 to shareholders of record at the...
Jul 30, 2020 06:30 am ET
Teleflex Reports Second Quarter 2020 Results
Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the second quarter ended June 28, 2020. Second quarter 2020 net revenues were $567.0 million, a decrease of 13.1% compared to the prior year period....
Jul 30, 2020 06:00 am ET
Teleflex Announces 200,000 Patients Treated with UroLift System for Enlarged Prostate
Teleflex Incorporated (NYSE: TFX) today announced that 200,000 patients have been treated with the minimally invasive UroLift® System for benign prostatic hyperplasia (BPH) worldwide. Affecting more than 40 million men in the United States alone,1...
Jul 21, 2020 06:30 am ET
Teleflex Announces Positive Data Emphasizing the Effectiveness of the UroLift® System Treatment for Enlarged Prostate Across Broad Patient Populations
Teleflex Incorporated (NYSE: TFX) today announced that data from three studies of the UroLift® System were presented at the European Association of Urology (EAU) 2020 virtual congress, underscoring the safety and effectiveness of the minimally...
Jul 20, 2020 06:30 am ET
Teleflex Announces Second Quarter 2020 Earnings Conference Call Information
Teleflex Incorporated (NYSE: TFX) announced today that financial results for the second quarter 2020 will be released before market open on Thursday, July 30, 2020.  An investor conference call will be held at 8:00 a.m. (ET) on Thursday, July 30,...
Jul 14, 2020 06:30 am ET
New Data Suggest Men May Want Non-Drug Alternatives For Treatment of Enlarged Prostate Symptoms
Teleflex Incorporated (NYSE: TFX) today announced results of a new survey showing that the majority of American men over age 40 are prescribed multiple medications to treat a variety of conditions, including benign prostatic hyperplasia (BPH), and...
Jun 23, 2020 06:30 am ET
Teleflex COVID 19 Humanitarian Product Donation Program
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced an online submission portal for its COVID‑19 Humanitarian Product Donation Program. As a global healthcare company operating in countries...
Jun 22, 2020 06:30 am ET
Teleflex Announces Publication of Early Patient Experience Data Highlighting the UroLift® System as a Superior Treatment to Rezum™ Steam Injection in Patients with Enlarged Prostate
Teleflex Incorporated (NYSE: TFX) today announced the publication of data from a study comparing patient experience of those treated with the UroLift® System for benign prostatic hyperplasia (BPH) to those who received the Rezum™ steam injection....
Jun 08, 2020 05:00 pm ET
In Honor of Men’s Health Month, Teleflex Announces Virtual Community Health Talk for Men with Benign Prostatic Hyperplasia
Teleflex Incorporated (NYSE: TFX) today announced that the company will host a free community health talk to discuss the symptoms, diagnosis and treatment options for enlarged prostate, also known as Benign Prostatic Hyperplasia (BPH). Dr. Wayne...
Jun 03, 2020 06:45 am ET
Teleflex to Present at the Raymond James 2020 Human Health Innovation Conference
Thomas Powell, Executive Vice President and Chief Financial Officer, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Raymond James 2020 Human Health Innovation Conference on Wednesday, June 17, 2020 at 2:20 p.m. (ET).  A live audio...
Jun 02, 2020 06:30 am ET
Teleflex Announces First Patient Enrollment in CTO-PCI IDE Study
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the first patient enrollment in a clinical study that will evaluate the performance of Teleflex coronary guidewires and specialty catheters in...
May 21, 2020 05:00 pm ET
Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering
Teleflex Incorporated (NYSE: TFX) (“Teleflex”) announced today that it priced its private offering of $500.0 million aggregate principal amount of 4.25% senior notes due 2028 (the “Notes”) at an issue price of 100.000%. The sale of the Notes is...
May 21, 2020 08:49 am ET
Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes due 2028
Teleflex Incorporated (NYSE: TFX) (“Teleflex”) announced today the commencement of a private offering of $500.0 million aggregate principal amount of senior notes due 2028 (the “Notes”), subject to market and other conditions. The interest rate and...
May 21, 2020 06:00 am ET
NeoTract Designates Dr. Naveen Divakaruni as UroLift® Center of Excellence
PLEASANTON, Calif., May 21, 2020 /PRNewswire-PRWeb/ -- NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Naveen Divakaruni, D.O., Advocate Medical Group in Aurora, IL, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Divakaruni has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as e
May 18, 2020 06:30 am ET
Teleflex Announces Positive Data Showing that the UroLift® System Effectively Relieves Enlarged Prostate Symptoms While Preserving Patients’ Sexual Function*
Teleflex Incorporated (NYSE: TFX) today announced that data from two analyses of the UroLift® System were presented at the American Urological Association (AUA) 2020 Virtual Science event. This new multimedia reinvention of the AUA 2020 poster and...
May 04, 2020 06:45 am ET
Teleflex Announces Quarterly Dividend
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock.  The dividend is payable June 15, 2020 to shareholders of record at the close...
May 04, 2020 06:30 am ET
Teleflex to Present at the UBS Virtual Global Healthcare Conference
Liam Kelly, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the UBS Virtual Global Healthcare Conference on Monday, May 18, 2020 at 10:50 a.m. (ET).  A live audio webcast of the conference presentation, along with...
Apr 30, 2020 06:30 am ET
Teleflex Reports First Quarter 2020 Results
Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the first quarter ended March 29, 2020. First quarter 2020 net revenues were $630.6 million, an increase of 2.8% compared to the prior year period. Excluding...
Apr 29, 2020 05:15 pm ET
Teleflex awarded Central Venous Access, Arterial Access agreements with Premier
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has been awarded group purchasing agreements for Central Venous Access and Arterial Access with Premier, effective July 1. Premier...
Apr 29, 2020 05:00 pm ET
ISO-Gard® Oxygen Mask Provides Oxygen Delivery While Scavenging Exhaled Breath
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, announced significant production expansion of the ISO-Gard® Mask, a product that supports patients and clinicians when oxygen assistance is required. The...
Apr 29, 2020 06:45 am ET
Teleflex to Present at the Bank of America Merrill Lynch 2020 Health Care Conference
Liam Kelly, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Bank of America Merrill Lynch 2020 Health Care Conference on Wednesday, May 13, 2020 at 4:20 p.m. (ET).  A live audio webcast of the conference...
Apr 20, 2020 05:00 pm ET
TELEFLEX ANNOUNCES FIRST QUARTER 2020 EARNINGS CONFERENCE CALL INFORMATION
Teleflex Incorporated (NYSE: TFX) announced today that financial results for the first quarter 2020 will be released before market open on Thursday, April 30, 2020.  An investor conference call will be held at 8:00 a.m. (ET) on Thursday, April 30,...
Apr 17, 2020 06:45 am ET
Teleflex Announces 2020 Annual Meeting of Stockholders to be Held in Virtual-Only Format
Teleflex Incorporated (NYSE: TFX) today announced that its 2020 annual meeting of stockholders (the “Annual Meeting”) will be conducted exclusively online by remote communication due to public health concerns regarding COVID-19 and...
Mar 11, 2020 06:45 am ET
Teleflex Celebrates 175,000 Patients Treated with the UroLift® System
Teleflex Incorporated (NYSE: TFX) today announced that 175,000 patients have now been treated globally* with its minimally invasive UroLift® System—a safe and effective treatment for Benign Prostatic Hyperplasia (BPH) that provides rapid symptom...
Feb 25, 2020 06:45 am ET
Teleflex to Present at Barclays Global Healthcare Conference
Liam Kelly, President and Chief Executive Officer, Teleflex Incorporated (NYSE:TFX), is scheduled to speak at Barclays Global Healthcare Conference at the Loews Miami Beach Hotel in Miami Beach, Florida, on Tuesday, March 10, 2020 at 9:00 am (ET)....
Feb 20, 2020 06:45 am ET
Teleflex Announces Quarterly Dividend
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable March 16, 2020 to shareholders of record at the close...
Feb 20, 2020 06:30 am ET
Teleflex Reports Fourth Quarter and Full Year 2019 Results; Provides 2020 Guidance
Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the fourth quarter and full year ended December 31, 2019. Fourth quarter 2019 net revenues were $681.0 million, an increase of 6.1% compared to the prior year...
Feb 18, 2020 05:00 pm ET
Teleflex to Present at the Raymond James 41st Annual Institutional Investors Conference
Liam Kelly, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Raymond James 41st Annual Institutional Investors Conference at the JW Marriott Grande Lakes in Orlando, Florida on Tuesday, March 3, 2020 at 3:25 p.m....
Feb 14, 2020 05:00 pm ET
Teleflex Incorporated Announces Worldwide Voluntary Recall of COMFORT FLO® Humidification System
Teleflex Incorporated (NYSE: TFX), a global provider of medical technologies for critical care and surgery, has announced a worldwide voluntary recall of the COMFORT FLO® Humidification System.  The recalled products provide a continuous flow of...
Feb 13, 2020 05:00 pm ET
Teleflex to Present at the 9th Annual SVB Leerink Global Healthcare Conference
Liam Kelly, President and CEO, Teleflex Incorporated (NYSE:TFX), is scheduled to speak at the 9th Annual SVB Leerink Global Healthcare Conference at the Lotte New York Palace Hotel in New York, NY, on Thursday, February 27, 2020 at 10:00 a.m. (ET)....
Feb 06, 2020 06:45 am ET
Teleflex Announces Fourth Quarter and Full Year 2019 Earnings Conference Call Information
Teleflex Incorporated (NYSE: TFX) announced today that financial results for the fourth quarter and full year 2019 will be released before market open on Thursday, February 20, 2020.  An investor conference call will be held at 8:00 a.m. (ET) on...
Jan 22, 2020 06:30 am ET
Teleflex Receives FDA Clearance for Wattson™ Temporary Pacing Guidewire
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, today announced that it received 510(k) clearance from the U.S. Food and Drug Administration for the WattsonTM Temporary Pacing...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.